Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents
- PMID: 37168463
- PMCID: PMC10158266
- DOI: 10.1097/PG9.0000000000000248
Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents
Abstract
We report 3 adolescents with cannabis hyperemesis syndrome and recurrent hypophosphatemia complicating their clinical course with potential for significant consequences. They serve as reminders for providers to consider the diagnosis of cannabis hyperemesis syndrome and to monitor serum electrolytes closely in the setting of adolescent hyperemesis.
Keywords: THC; cannabis; cyclic vomiting; pediatric emergency department; teenagers; urine toxicology.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Figures
References
-
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). 2020. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.
-
- Hernandez JM, Paty J, Price IM. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area [Internet]. Vol. 20, Canadian Journal of Emergency Medicine. Cambridge University Press; 2018; [cited 2021 Feb 8]:550–555. - PubMed
-
- Lonsdale H, Kimsey KM, Brown JM, et al. . Pediatric cannabinoid hyperemesis: a single institution 10-year case series. J Adolesc Health. 2021;68:255–261. - PubMed
LinkOut - more resources
Full Text Sources
